Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 91.53
+1.52 (1.69%)
Aug 15, 2025, 2:45 PM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.10B CNY in the quarter ending March 31, 2025, with 47.86% growth. This brings the company's revenue in the last twelve months to 3.91B, up 57.51% year-over-year. In the year 2024, Shanghai Allist Pharmaceuticals had annual revenue of 3.56B with 76.29% growth.
Revenue (ttm)
3.91B
Revenue Growth
+57.51%
P/S Ratio
10.52
Revenue / Employee
2.76M
Employees
1,417
Market Cap
41.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.56B | 1.54B | 76.29% |
| Dec 31, 2023 | 2.02B | 1.23B | 155.14% |
| Dec 31, 2022 | 791.00M | 260.91M | 49.22% |
| Dec 31, 2021 | 530.09M | 529.53M | 94,409.97% |
| Dec 31, 2020 | 560.89K | -68.84K | -10.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| WuXi AppTec | 41.48B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |